{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T21:30:02Z","timestamp":1782509402755,"version":"3.54.5"},"reference-count":82,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22890064"],"award-info":[{"award-number":["22890064"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23790595"],"award-info":[{"award-number":["23790595"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26860354"],"award-info":[{"award-number":["26860354"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K09408"],"award-info":[{"award-number":["17K09408"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K19333"],"award-info":[{"award-number":["16K19333"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The pancreas is a key organ involved in digestion and endocrine functions in the body. The major diseases of the pancreas include pancreatitis, pancreatic cancer, cystic diseases, pancreatic divisum, islet cell tumors, endocrine tumors, diabetes mellitus, and pancreatic pain induced by these diseases. While various therapeutic methodologies have been established to date, however, the improvement of conventional treatments and establishment of novel therapies are essential to improve the efficacy. For example, conventional therapeutic options, including chemotherapy, are not effective against pancreatic cancer, and despite improvements in the last decade, the mortality rate has not declined and is estimated to become the second cause of cancer-related deaths by 2030. Therefore, continuous efforts focus on the development of novel therapeutic options. In this review, we will summarize the progress toward the development of gene therapies for pancreatic diseases, with an emphasis on recent preclinical studies and clinical trials. We aim to identify new areas for improvement of the current methodologies and new strategies that will lead to safe and effective gene therapeutic approaches in pancreatic diseases.<\/jats:p>","DOI":"10.3390\/ijms19113415","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T11:55:41Z","timestamp":1540986941000},"page":"3415","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Gene Therapy for Pancreatic Diseases: Current Status"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7182-4400","authenticated-orcid":false,"given":"Kenya","family":"Kamimura","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 1-757, Aasahimachi-Dori, Chuo-Ku, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7138-1785","authenticated-orcid":false,"given":"Takeshi","family":"Yokoo","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 1-757, Aasahimachi-Dori, Chuo-Ku, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Terai","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 1-757, Aasahimachi-Dori, Chuo-Ku, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,10,31]]},"reference":[{"key":"ref_1","unstructured":"Stringer, M.D. (2015). Gray\u2019s Anatomy, the Anatomical Basis of Clinical Practice London, Churchill Livingstone. [41st ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Saad, A.M., Turk, T., Al-Husseini, M.J., and Abdel-Rahman, O. (2018). Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4610-4"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1097\/MPA.0000000000001098","article-title":"Clinical features and prognosis of patients With the bone metastasis of pancreatic cancer: A single-institutional cohort study","volume":"47","author":"Outani","year":"2018","journal-title":"Pancreas"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/MPA.0000000000001085","article-title":"The potential of glycemic control and body weight change as early markers for pancreatic cancer in patients with long-standing diabetes mellitus: A case-control study","volume":"47","author":"Mueller","year":"2018","journal-title":"Pancreas"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-018-0235-7","article-title":"Altered exocrine function can drive adipose wasting in early pancreatic cancer","volume":"558","author":"Danai","year":"2018","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"11142","DOI":"10.3748\/wjg.v20.i32.11142","article-title":"Therapeutic options for the management of pancreatic cancer","volume":"20","author":"Rossi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hegewisch-Becker, S., Aldaoud, A., Wolf, T., Krammer-Steiner, B., Linde, H., Scheiner-Sparna, R., Hamm, D., J\u00e4nicke, M., and Marschner, N. (2018). Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1174 patients with locally advanced, inoperable or metastatic pancreatic ductal adenocarcinoma. Int. J. Cancer.","DOI":"10.1002\/ijc.31751"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Pishvaian, M.J., Bender, R.J., Halverson, D., Rahib, L., Hendifar, A.E., Mikhail, S., Chung, V., Picozzi, V.J., Sohal, D., and Blais, E.M. (2018). Molecular profiling of pancreatic cancer patients: Initial results from the know your tumor initiative. Clin. Cancer Res.","DOI":"10.1158\/1078-0432.CCR-18-0531"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Rouanet, M., Lebrin, M., Gross, F., Bournet, B., Cordelier, P., and Buscail, L. (2017). Gene therapy for pancreatic cancer: Specificity, issues and hopes. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061231"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1001\/jama.2018.6228","article-title":"Association Between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer","volume":"319","author":"Hu","year":"2018","journal-title":"JAMA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1053\/j.gastro.2013.01.071","article-title":"Roles for KRAS in pancreatic tumor development and progression","volume":"144","author":"Logsdon","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13046-018-0807-2","article-title":"Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4","volume":"37","author":"Fu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.bbrc.2018.06.145","article-title":"SALL4 suppresses reactive oxygen species in pancreatic ductal adenocarcinoma phenotype via FoxM1\/Prx III axis","volume":"503","author":"Huynh","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.tranon.2018.03.003","article-title":"Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression microarray Analysis in Pancreatic Cancer","volume":"11","author":"Liu","year":"2018","journal-title":"Transl. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/bjs.10187","article-title":"Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma","volume":"103","author":"Wang","year":"2016","journal-title":"Br. J. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41556-018-0122-3","article-title":"Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism","volume":"20","author":"Patra","year":"2018","journal-title":"Nat. Cell. Biol."},{"key":"ref_19","first-page":"1268","article-title":"Gene therapy with Adv-IL-2 in unresectable digestive cancer: Phase I-II study, intermediate report","volume":"46","author":"Gilly","year":"1999","journal-title":"HepatoGastroenterology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.gt.3301398","article-title":"Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: A phase I trial","volume":"8","author":"Mulvihill","year":"2001","journal-title":"Gene Ther."},{"key":"ref_21","first-page":"78","article-title":"Treatment of inoperable pancreatic carcinoma using a cell-based local chemotherapy: Results of a phase I\/II clinical trial","volume":"38","author":"Salmons","year":"2003","journal-title":"J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00262-002-0317-z","article-title":"Mucin gene (MUC1) transfected dendritic cells as vaccine: Results of a phase I\/II clinical trial","volume":"51","author":"Pecher","year":"2002","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_23","first-page":"555","article-title":"A phase I\/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma","volume":"9","author":"Hecht","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_24","first-page":"177","article-title":"First clinical experience using a \u2018pathotropic\u2019 injectable retroviral vector (Rexin-G) as intervention for stage IV pancreatic cancer","volume":"24","author":"Gordon","year":"2004","journal-title":"Int. J. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2004.04.059","article-title":"Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors","volume":"22","author":"Sangro","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1200\/JCO.2004.01.227","article-title":"TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: A phase I study in patients with solid tumors","volume":"22","author":"Senzer","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1200\/JCO.2005.00.463","article-title":"Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas","volume":"23","author":"Mazzolini","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1479-5876-5-60","article-title":"Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer","volume":"5","author":"Kaufman","year":"2007","journal-title":"J. Transl. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1158\/1078-0432.CCR-07-0371","article-title":"Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: A pilot study of safety, feasibility, and immune activation","volume":"14","author":"Laheru","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/mt.2009.228","article-title":"Advanced phase I\/II studies of targeted gene delivery in vivo: Intravenous Rexin-G for gemcitabine-resistant metastatic pancreatic cancer","volume":"18","author":"Chawla","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/cgt.2010.65","article-title":"A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer","volume":"18","author":"Nakao","year":"2011","journal-title":"Cancer Gene Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1089\/hum.2011.153","article-title":"Mutated Ras-transfected, EBV-transformed lymphoblastoid cell lines as a model tumor vaccine for boosting T-cell responses against pancreatic cancer: A pilot trial","volume":"23","author":"Kubuschok","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/cgt.2012.10","article-title":"Phase 1\/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer","volume":"19","author":"Hanna","year":"2012","journal-title":"Cancer Gene Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.gie.2011.10.007","article-title":"EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: A phase I\/II study","volume":"75","author":"Hecht","year":"2012","journal-title":"Gastrointest. Endosc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1158\/1078-0432.CCR-11-2121","article-title":"A live-attenuated listeria vaccine (ANZ-100) and a live-attenuated listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: Phase I studies of safety and immune induction","volume":"18","author":"Le","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11605-012-2064-6","article-title":"Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: A phase 2 study","volume":"17","author":"Hardacre","year":"2013","journal-title":"J. Gastrointest. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1200\/JCO.2012.44.7516","article-title":"Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: Final results","volume":"31","author":"Herman","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/pharmaceutics6030447","article-title":"Encapsulated cells expressing a chemotherapeutic activating enzyme allow the targeting of subtoxic chemotherapy and are safe and efficacious: Data from two clinical trials in pancreatic cancer","volume":"6","author":"Haas","year":"2014","journal-title":"Pharmaceutics"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00262-015-1679-3","article-title":"Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma","volume":"64","author":"Aguilar","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"24560","DOI":"10.18632\/oncotarget.4183","article-title":"RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients","volume":"6","author":"Golan","year":"2015","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1200\/JCO.2014.57.4244","article-title":"Safety and survival with GVAX pancreas prime and Listeria monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer","volume":"33","author":"Le","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/mt.2016.66","article-title":"Randomized Phase 2 trial of the oncolytic virus Pelareorep (Reolysin) in upfront treatment of metastatic pancreatic adenocarcinoma","volume":"24","author":"Noonan","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Inoko, K., Hiraoka, K., Inagaki, A., Takahashi, M., Kushibiki, T., Hontani, K., Takano, H., Sato, S., Takeuchi, S., and Nakamura, T. (2018). Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer. Cancer Gene Ther.","DOI":"10.1038\/s41417-018-0020-7"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/mt.2015.1","article-title":"First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: Safety, biodistribution, and preliminary clinical findings","volume":"23","author":"Buscail","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/mt.2008.29","article-title":"Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer","volume":"16","author":"Galanis","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/SLA.0b013e3181fd271c","article-title":"A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation","volume":"253","author":"Lutz","year":"2011","journal-title":"Ann. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/CJI.0b013e31829fb7a2","article-title":"Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer","volume":"36","author":"Le","year":"2013","journal-title":"J Immunother"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Thakar, M., Hu, Y., Morreale, M., Lerner, L., Ying Lin, W., Sen, R., Cai, Y., Karunasena, E., Thakar, M., and Saggi, S. (2018). A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0199130"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e791","DOI":"10.1038\/cddis.2013.307","article-title":"Gemcitabine-mediated tumour regression and p53-dependent gene expression: Implications for colon and pancreatic cancer therapy","volume":"4","author":"Hill","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Liu, B., Yang, H., Pilarsky, C., and Weber, G.F. (2018). The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3\u03b2 in Pancreatic Cancer. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19071870"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e3015","DOI":"10.1002\/jgm.3015","article-title":"Gene therapy clinical trials worldwide to 2017: An update","volume":"20","author":"Ginn","year":"2018","journal-title":"J. Gene Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/hum.2015.141","article-title":"The Promise of gene therapy for pancreatic cancer","volume":"27","author":"Vassaux","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/gt.2009.74","article-title":"Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer","volume":"16","author":"Tysome","year":"2009","journal-title":"Gene Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/mt.2013.35","article-title":"Targeting miR-21 for the therapy of pancreatic cancer","volume":"21","author":"Sicard","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Hassan, F., Lossie, S.L., Kasik, E.P., Channon, A.M., Ni, S., and Kennedy, M.A. (2018). A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic HMGA1 as a new cancer treatment therapy. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192882"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/hgtb.2016.089","article-title":"Efficient gene delivery and expression in pancreas and pancreatic tumors by capsid-optimized AAV8 vectors","volume":"28","author":"Chen","year":"2017","journal-title":"Hum. Gene Ther. Methods"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Lucas, T., Benihoud, K., Vigant, F., Schmidt, C.Q., Wortmann, A., Bachem, M.G., Simmet, T., and Kochanek, S. (2015). Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117254"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/hum.2014.072","article-title":"Targeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors","volume":"26","author":"Gayral","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Rejiba, S., Bigand, C., Parmentier, C., Masmoudi, A., and Hajri, A. (2013). Oncosuppressive suicide gene virotherapy \u201cPVH1-yCD\/5-FC\u201d for pancreatic peritoneal carcinomatosis treatment: NF-\u03baB and Akt\/PI3K involvement. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070594"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nmeth.3993","article-title":"A multifunctional AAV-CRISPR-Cas9 and its host response","volume":"13","author":"Chew","year":"2016","journal-title":"Nat. Methods"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1101\/gad.264861.115","article-title":"Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR\/Cas9-mediated somatic genome editing","volume":"29","author":"Chiou","year":"2015","journal-title":"Genes Dev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/cgt.2016.66","article-title":"T-cell programming in pancreatic adenocarcinoma: A review","volume":"24","author":"Seo","year":"2017","journal-title":"Cancer Gene Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ymthe.2016.10.016","article-title":"Improving chimeric antigen receptor-modified T cell function by reversing the immunosuppressive tumor microenvironment of pancreatic cancer","volume":"25","author":"Mohammed","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jso.24627","article-title":"CAR T-cell therapy for pancreatic cancer","volume":"116","author":"DeSelm","year":"2017","journal-title":"J. Surg. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/MOP.0000000000000668","article-title":"Genetic predisposition in pancreatitis","volume":"30","author":"Gonska","year":"2018","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1089\/hum.2015.158","article-title":"Long-term retrospective analysis of gene therapy with alipogene tiparvovec and its effect on lipoprotein lipase deficiency-induced pancreatitis","volume":"27","author":"Gaudet","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.3748\/wjg.v19.i38.6319","article-title":"Pain in chronic pancreatitis: Managing beyond the pancreatic duct","volume":"19","author":"Talukdar","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1053\/j.gastro.2018.02.030","article-title":"Neuronal transforming growth factor beta signaling via SMAD3 contributes to pain in animal models of chronic pancreatitis","volume":"154","author":"Liu","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/sj.mt.6300228","article-title":"Treatment of inflamed pancreas with enkephalin encoding HSV-1 recombinant vector reduces inflammatory damage and behavioral sequelae","volume":"15","author":"Lu","year":"2007","journal-title":"Mol. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1744-8069-4-8","article-title":"Enkephalin-encoding herpes simplex virus-1 decreases inflammation and hotplate sensitivity in a chronic pancreatitis model","volume":"4","author":"Yang","year":"2008","journal-title":"Mol. Pain"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/pedi.12669","article-title":"Permanent neonatal diabetes mellitus and neurological abnormalities due to a novel homozygous missense mutation in NEUROD1","volume":"19","author":"Demirbilek","year":"2018","journal-title":"Pediatr. Diabetes"},{"key":"ref_72","first-page":"37","article-title":"Insulin gene therapy for type 1 diabetes mellitus","volume":"13","author":"Handorf","year":"2015","journal-title":"Exp. Clin. Transplant."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e9431","DOI":"10.15252\/emmm.201809431","article-title":"AAV-mediated gene therapy as a strategy to fight obesity and metabolic diseases","volume":"10","author":"Sponton","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1017\/erm.2014.7","article-title":"GLP-1-mediated gene therapy approaches for diabetes treatment","volume":"16","author":"Tasyurek","year":"2014","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.ymthe.2018.02.014","article-title":"Long-term correction of diabetes in mice by in vivo reprogramming of pancreatic ducts","volume":"26","author":"Wang","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bbrc.2018.03.036","article-title":"Induction of hepatocytes-derived insulin-producing cells using small molecules and identification of microRNA profiles during this procedure","volume":"498","author":"Pan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Zickri, M.B., Aboul-Fotouh, G.I., Omar, A.I., El-Shafei, A.A., and Reda, A.M. (2018). Effect of stem cells and gene transfected stem cells therapy on the pancreas of experimentally induced Type 1 diabetes. Int. J. Stem Cells.","DOI":"10.15283\/ijsc18002"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Jimenez, V., Jambrina, C., Casana, E., Sacristan, V., Mu\u00f1oz, S., Darriba, S., Rod\u00f3, J., Mallol, C., Garcia, M., and Le\u00f3n, X. (2018). FGF21 gene therapy as treatment for obesity and insulin resistance. EMBO Mol. Med., 10.","DOI":"10.15252\/emmm.201708791"},{"key":"ref_79","first-page":"293","article-title":"Advances in gene delivery systems","volume":"25","author":"Kamimura","year":"2011","journal-title":"Pharmaceut. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.omtn.2017.08.009","article-title":"Efficacy and safety of pancreas-targeted hydrodynamic gene delivery in rats","volume":"9","author":"Ogawa","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"eaar8409","DOI":"10.1126\/sciadv.aar8409","article-title":"Endothelial siRNA delivery in nonhuman primates using ionizable low-molecular weight polymeric nanoparticles","volume":"4","author":"Khan","year":"2018","journal-title":"Sci Adv."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Gorgulu, K., Diakopoulos, K.N., Ai, J., Schoeps, B., Kabacaoglu, D., Karpathaki, AF., Ciecielski, K.J., Kaya-Aksoy, E., Ruess, D.A., and Berninger, A. (2018). Levels of the autophagy related 5 protein affect progression and metastasis of pancreatic tumors in mice. Gastroenterology.","DOI":"10.1053\/j.gastro.2018.09.053"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/11\/3415\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:27:09Z","timestamp":1760196429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/11\/3415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":82,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"alternative-id":["ijms19113415"],"URL":"https:\/\/doi.org\/10.3390\/ijms19113415","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,31]]}}}